Literature DB >> 17339335

Thymomegaly, microsplenia, and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice.

Tsukasa Higuchi1, Frank O Bartel, Masahiro Masuya, Takao Deguchi, Kelly W Henderson, Runzhao Li, Robin C Muise-Helmericks, Michael J Kern, Dennis K Watson, Demetri D Spyropoulos.   

Abstract

Ets1 is a member of the Ets transcription factor family. Alternative splicing of exon VII results in two naturally occurring protein isoforms: full-length Ets1 (p51-Ets1) and Ets1(DeltaVII) (p42-Ets1). These isoforms bear key distinctions regarding protein-protein interactions, DNA binding kinetics, and transcriptional target specificity. Disruption of both Ets1 isoforms in mice results in the loss of detectable NK and NKT cell activity and defects in B and T lymphocytes. We generated mice that express only the Ets1(DeltaVII) isoform. Ets1(DeltaVII) homozygous mice express no p51-Ets1 and elevated levels of the p42-Ets1 protein relative to the wild type and display increased perinatal lethality, thymomegaly, and peripheral lymphopenia. Proliferation was increased in both the thymus and the spleen, while apoptosis was decreased in the thymus and increased in the spleen of homozygotes. Significant elevations of CD8(+) and CD8(+)CD4(+) thymocytes were observed. Lymphoid cell (CD19(+), CD4(+), and CD8(+)) reductions were predominantly responsible for diminished spleen cellularity, with fewer memory cells and a failure of homeostatic proliferation to maintain peripheral lymphocytes. Collectively, the Ets1(DeltaVII) mutants demonstrate lymphocyte maturation defects associated with misregulation of p16(Ink4a), p27(Kip1), and CD44. Thus, a balance in the differential regulation of Ets1 isoforms represents a potential mechanism in the control of lymphoid maturation and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17339335      PMCID: PMC1899970          DOI: 10.1128/MCB.01871-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

1.  Low activation threshold as a mechanism for ligand-independent signaling in pre-T cells.

Authors:  Mariëlle C Haks; Stanley M Belkowski; Maria Ciofani; Michele Rhodes; Juliette M Lefebvre; Sebastién Trop; Patrice Hugo; Juan Carlos Zúñiga-Pflücker; David L Wiest
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

Review 2.  CD44: from adhesion molecules to signalling regulators.

Authors:  Helmut Ponta; Larry Sherman; Peter A Herrlich
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

3.  Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts.

Authors:  Thomas J Huot; Janice Rowe; Mark Harland; Sarah Drayton; Sharon Brookes; Chandra Gooptu; Patricia Purkis; Mike Fried; Veronique Bataille; Eiji Hara; Julia Newton-Bishop; Gordon Peters
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  CD44-stimulated human B cells express transcripts specifically involved in immunomodulation and inflammation as analyzed by DNA microarrays.

Authors:  Carl-Magnus Högerkorp; Sven Bilke; Thomas Breslin; Sigurdur Ingvarsson; Carl A K Borrebaeck
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

5.  Calcium regulation of GM-CSF by calmodulin-dependent kinase II phosphorylation of Ets1.

Authors:  Hebin Liu; Thomas Grundström
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

6.  ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition.

Authors:  David Baillat; Agnès Bègue; Dominique Stéhelin; Marc Aumercier
Journal:  J Biol Chem       Date:  2002-05-28       Impact factor: 5.157

7.  Removal of the floxed neo gene from a conditional knockout allele by the adenoviral Cre recombinase in vivo.

Authors:  V Kaartinen; A Nagy
Journal:  Genesis       Date:  2001-11       Impact factor: 2.487

8.  Transgenic expression of the p16(INK4a) cyclin-dependent kinase inhibitor leads to enhanced apoptosis and differentiation arrest of CD4-CD8- immature thymocytes.

Authors:  Chantal Lagresle; Betty Gardie; Stéphanie Eyquem; Magali Fasseu; Jean-Claude Vieville; Marika Pla; François Sigaux; Jean-Christophe Bories
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

9.  Normal sequence of phenotypic transitions in one cohort of 5-bromo-2'-deoxyuridine-pulse-labeled thymocytes. Correlation with T cell receptor expression.

Authors:  B Lucas; F Vasseur; C Penit
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

10.  Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells.

Authors:  Pia Ballschmieter; Melanie Braig; Ralph K Lindemann; Alfred Nordheim; Jürgen Dittmer
Journal:  Int J Oncol       Date:  2003-04       Impact factor: 5.650

View more
  10 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

2.  Ets1 is required for proper migration and differentiation of the cardiac neural crest.

Authors:  Zhiguang Gao; Gene H Kim; Alexander C Mackinnon; Alleda E Flagg; Brett Bassett; Judy U Earley; Eric C Svensson
Journal:  Development       Date:  2010-03-31       Impact factor: 6.868

3.  Analysis of gene networks in white adipose tissue development reveals a role for ETS2 in adipogenesis.

Authors:  Kivanç Birsoy; Ryan Berry; Tim Wang; Ozge Ceyhan; Saeed Tavazoie; Jeffrey M Friedman; Matthew S Rodeheffer
Journal:  Development       Date:  2011-11       Impact factor: 6.868

4.  Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1.

Authors:  Kevin Ramirez; Katherine J Chandler; Christina Spaulding; Sasan Zandi; Mikael Sigvardsson; Barbara J Graves; Barbara L Kee
Journal:  Immunity       Date:  2012-05-17       Impact factor: 31.745

5.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

Review 6.  Review of Ets1 structure, function, and roles in immunity.

Authors:  Lee Ann Garrett-Sinha
Journal:  Cell Mol Life Sci       Date:  2013-01-05       Impact factor: 9.261

7.  ETS-1-mediated transcriptional up-regulation of CD44 is required for sphingosine-1-phosphate receptor subtype 3-stimulated chemotaxis.

Authors:  Wenliang Zhang; Jiawei Zhao; Jen-Fu Lee; Allison Gartung; Hiba Jawadi; Wanyu Louis Lambiv; Kenneth V Honn; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2013-09-24       Impact factor: 5.157

8.  The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus.

Authors:  Monica Zamisch; Linhua Tian; Roland Grenningloh; Yumei Xiong; Kathryn F Wildt; Marc Ehlers; I-Cheng Ho; Rémy Bosselut
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

9.  The level of Ets-1 protein is regulated by poly(ADP-ribose) polymerase-1 (PARP-1) in cancer cells to prevent DNA damage.

Authors:  Arnaud J Legrand; Souhaila Choul-Li; Corentin Spriet; Thierry Idziorek; Dorothée Vicogne; Hervé Drobecq; Françoise Dantzer; Vincent Villeret; Marc Aumercier
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.

Authors:  Virgil A S H Dalm; Gertjan J A Driessen; Barbara H Barendregt; Petrus M van Hagen; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2015-11-14       Impact factor: 8.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.